Lloyd A Rowland Cytom X Therapeutics, Inc. (CTMX) insider trading activity
Lloyd A Rowland is General Counsel of CytomX Therapeutics, Inc.. Currently has a direct ownership of 130,797 shares of CTMX, which is worth approximately $138,644. The most recent transaction as insider was on Aug 20, 2024, when has been sold 4,181 shares (Common Stock) at a price of $1.23 per share, resulting in proceeds of $5,142. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
131K
0%
3M change
28.14%
12M change
Total Value Held
$138,644
LLOYD A ROWLAND Transaction History
LAR
Lloyd A Rowland
General Counsel
South San Francisco, CA